Literature DB >> 16982841

Differences in the growth of paired Ugandan isolates of Mycobacterium tuberculosis within human mononuclear phagocytes correlate with epidemiological evidence of strain virulence.

Sue A Theus1, M Donald Cave, Kathleen Eisenach, Jessica Walrath, Hung Lee, Wilma Mackay, Christopher Whalen, Richard F Silver.   

Abstract

Previous studies have suggested that isolates of Mycobacterium tuberculosis responsible for tuberculosis outbreaks grow more rapidly within human mononuclear phagocytes than do other isolates. Clinical scenarios suggesting virulence of specific M. tuberculosis isolates are readily identified. Determination of appropriate "control" isolates for these studies is more problematic, but equally important for validating these assays and, ultimately, for identifying biologic differences between M. tuberculosis strains that contribute to virulence. We utilized the database from a study of Ugandan tuberculosis patients and their household (HH) contacts to identify M. tuberculosis isolates transmitted within HH and nontransmitted control isolates. Isolate pairs were evaluated from matched HH in each of three clinical scenarios: (i) coprevalent disease and no disease, (ii) incident disease and no disease, and (iii) M. tuberculosis infection (purified protein derivative [PPD] positive) and no infection (PPD negative). Intracellular growth of paired organisms was determined in a blinded fashion using two models of intracellular infection in which we have previously demonstrated correlation between intracellular growth and strain virulence, primary human monocytes (MN) and THP-1 human macrophage-like cells. In both models, transmitted isolates from coprevalent disease HH displayed more rapid growth than nontransmitted control isolates. In the THP-1 model, this was also true of transmitted isolates from HH with incident disease and their controls. Differences in production of tumor necrosis factor alpha and interleukin-10 by matched isolates showed correlation with growth patterns in the THP-1 cells but not in MN. Paired isolates characterized in this manner may be of particular interest for further investigations of the virulence of M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982841      PMCID: PMC1698107          DOI: 10.1128/IAI.00561-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  The effect of bacille Calmette-Guérin vaccination at birth on tuberculin skin test reactivity in Ugandan children.

Authors:  P M Mudido; D Guwatudde; M K Nakakeeto; G B Bukenya; D Nsamba; J L Johnson; R D Mugerwa; J J Ellner; C C Whalen
Journal:  Int J Tuberc Lung Dis       Date:  1999-10       Impact factor: 2.373

3.  Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis.

Authors:  Isabelle Vergne; Jennifer Chua; Hwang-Ho Lee; Megan Lucas; John Belisle; Vojo Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

4.  Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates.

Authors:  C Manca; L Tsenova; C E Barry; A Bergtold; S Freeman; P A Haslett; J M Musser; V H Freedman; G Kaplan
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

5.  Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages.

Authors:  M Zhang; J Gong; Z Yang; B Samten; M D Cave; P F Barnes
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

6.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

7.  Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects.

Authors:  R F Silver; Q Li; W H Boom; J J Ellner
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

8.  Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages.

Authors:  M Zhang; J Gong; Y Lin; P F Barnes
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

9.  Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics.

Authors:  Sue A Theus; M Donald Cave; Kathleen D Eisenach
Journal:  J Infect Dis       Date:  2004-12-30       Impact factor: 5.226

10.  Multiplication and survival of tubercle bacilli in the organs of mice.

Authors:  C H PIERCE; R J DUBOS; W B SCHAEFER
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

View more
  9 in total

1.  Evaluation of the inaccurate assignment of mixed infections by Mycobacterium tuberculosis as exogenous reinfection and analysis of the potential role of bacterial factors in reinfection.

Authors:  Ana Martín; Marta Herranz; Yurena Navarro; Sandra Lasarte; María Jesús Ruiz Serrano; Emilio Bouza; Darío García de Viedma
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

2.  Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar.

Authors:  Niaina Rakotosamimanana; Vaomalala Raharimanga; Soa Fy Andriamandimby; Jean-Louis Soares; T Mark Doherty; Maherisoa Ratsitorahina; Herimanana Ramarokoto; Alimuddin Zumla; Jim Huggett; Graham Rook; Vincent Richard; Brigitte Gicquel; Voahangy Rasolofo-Razanamparany
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

3.  Characterization of Mycobacterium tuberculosis Beijing isolates from the Mediterranean area.

Authors:  M Alonso; N Alonso Rodriguez; C Garzelli; M Martínez Lirola; M Herranz; S Samper; M J Ruiz Serrano; E Bouza; D García de Viedma
Journal:  BMC Microbiol       Date:  2010-05-25       Impact factor: 3.605

4.  Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis.

Authors:  Manzour Hernando Hazbón; Alifiya S Motiwala; Magali Cavatore; Michael Brimacombe; Thomas S Whittam; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

5.  Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy.

Authors:  Alessandra Romagnoli; Elisa Petruccioli; Ivana Palucci; Serena Camassa; Elisabetta Carata; Linda Petrone; Stefania Mariano; Michela Sali; Luciana Dini; Enrico Girardi; Giovanni Delogu; Delia Goletti; Gian Maria Fimia
Journal:  Cell Death Dis       Date:  2018-05-24       Impact factor: 8.469

6.  Genetically Related Mycobacterium bovis Strains Displayed Differential Intracellular Growth in Bovine Macrophages.

Authors:  Alejandro Benítez-Guzmán; Hugo Esquivel-Solís; Cecilia Romero-Torres; Camila Arriaga-Díaz; José A Gutiérrez-Pabello
Journal:  Vet Sci       Date:  2019-10-18

7.  Differential immune responses to Segniliparus rotundus and Segniliparus rugosus infection and analysis of their comparative virulence profiles.

Authors:  Jong-Seok Kim; Woo Sik Kim; Keehoon Lee; Choul-Jae Won; Jin Man Kim; Seok-Yong Eum; Won-Jung Koh; Sung Jae Shin
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

8.  Draft Genome Sequence of Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolate OSDD515, Belonging to the Uganda I Genotype.

Authors:  Shamsudheen Karuthedath Vellarikkal; Ajay Vir Singh; Pravin Kumar Singh; Parul Garg; Viswa Mohan Katoch; Kiran Katoch; D S Chauhan; Sridhar Sivasubbu; Vinod Scaria
Journal:  Genome Announc       Date:  2013-11-21

Review 9.  Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.

Authors:  Leopold D Tientcheu; Anastasia Koch; Mthawelenga Ndengane; Genevieve Andoseh; Beate Kampmann; Robert J Wilkinson
Journal:  Eur J Immunol       Date:  2017-02-24       Impact factor: 5.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.